Kadmon Corporation, LLC - Product Pipeline Review - 2014

Published: Dec, 2014 | Pages: 44 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Kadmon Corporation, LLC - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Kadmon Corporation, LLC - Product Pipeline Review - 2014', provides an overview of the Kadmon Corporation, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kadmon Corporation, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Kadmon Corporation, LLC including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kadmon Corporation, LLC's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Kadmon Corporation, LLC's pipeline products

Reasons to buy

- Evaluate Kadmon Corporation, LLC's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Kadmon Corporation, LLC in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Kadmon Corporation, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Kadmon Corporation, LLC and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kadmon Corporation, LLC
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Kadmon Corporation, LLC and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Kadmon Corporation, LLC Snapshot 5
Kadmon Corporation, LLC Overview 5
Key Information 5
Key Facts 5
Kadmon Corporation, LLC - Research and Development Overview 6
Key Therapeutic Areas 6
Kadmon Corporation, LLC - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Kadmon Corporation, LLC - Pipeline Products Glance 11
Kadmon Corporation, LLC - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Kadmon Corporation, LLC - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Kadmon Corporation, LLC - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Kadmon Corporation, LLC - Drug Profiles 16
KD-019 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
KD-020 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
KD-025 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
KD-026 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
KD-027 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
salirasib 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Gene Therapy to Activate Aquaporin-1 for Xerostomia 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
KD-014 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
KD-033 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Monoclonal Antibody to Inhibit VEGFR-2 for Colorectal Cancer 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Small Molecule to Inhibit pan-ROCK 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Small Molecule to Selectively Inhibit ROCK2 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Small Molecules to Inhibit Acetyl-CoA Carboxylase for CMV Infections 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Kadmon Corporation, LLC - Pipeline Analysis 31
Kadmon Corporation, LLC - Pipeline Products by Target 31
Kadmon Corporation, LLC - Pipeline Products by Route of Administration 33
Kadmon Corporation, LLC - Pipeline Products by Molecule Type 34
Kadmon Corporation, LLC - Pipeline Products by Mechanism of Action 35
Kadmon Corporation, LLC - Recent Pipeline Updates 37
Kadmon Corporation, LLC - Dormant Projects 41
Kadmon Corporation, LLC - Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 44
Disclaimer 44

List of Tables
Kadmon Corporation, LLC, Key Information 5
Kadmon Corporation, LLC, Key Facts 5
Kadmon Corporation, LLC - Pipeline by Indication, 2014 8
Kadmon Corporation, LLC - Pipeline by Stage of Development, 2014 9
Kadmon Corporation, LLC - Monotherapy Products in Pipeline, 2014 10
Kadmon Corporation, LLC - Phase III, 2014 11
Kadmon Corporation, LLC - Phase II, 2014 12
Kadmon Corporation, LLC - Phase I, 2014 13
Kadmon Corporation, LLC - Preclinical, 2014 14
Kadmon Corporation, LLC - Discovery, 2014 15
Kadmon Corporation, LLC - Pipeline by Target, 2014 32
Kadmon Corporation, LLC - Pipeline by Route of Administration, 2014 33
Kadmon Corporation, LLC - Pipeline by Molecule Type, 2014 34
Kadmon Corporation, LLC - Pipeline Products by Mechanism of Action, 2014 36
Kadmon Corporation, LLC - Recent Pipeline Updates, 2014 37
Kadmon Corporation, LLC - Dormant Developmental Projects,2014 41
Kadmon Corporation, LLC, Other Locations 42
Kadmon Corporation, LLC, Subsidiaries 42